Company insider dossier

Teva Pharma Industries Ltd ADR insider intelligence

TEVA filings assessed for conviction, transaction quality, insider breadth, clustering, freshness, and price confirmation.

Terminal chart Weekly report Factor intelligence Healthcare Drug Manufacturers - Specialty & Generic Data API
12/100

Concentrated distribution

89/100 confidence
Exchange
NYSE
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Latest evidence
5 Aug 2026

Investment committee read

Concentrated distribution

Priced common-share disposals are concentrated enough to warrant review, but they are not treated as a standalone bearish forecast.

Review exposure and filing context

Evidence in favour

  • Participation spans 19 named insiders rather than one filing source.
  • The latest qualifying evidence is fresh, dated 05 Aug 2026.

Decision risks

  • Qualifying disposal events outnumber acquisitions, although disposals receive a lower directional weight.
Conviction12Concentrated distribution
Confidence89Deep evidence
Named insiders19participating in the tape
Controlled events15directional common-share events
Acquisition value$0normalized amount
Disposal value$22.1Mnormalized amount

Price confirmation map

Weekly price with common-share events

Acquisitions and disposals are aligned to the nearest completed weekly bar.

35.7330.1624.5919.0313.46 Disposal · 5 Aug 2026 · $593Acquisition · 3 Aug 2026 · Not reportedAcquisition · 3 Aug 2026 · Not reportedDisposal · 3 Aug 2026 · $892.1KDisposal · 3 Aug 2026 · $447.4KDisposal · 18 Jun 2026 · $321.5KDisposal · 11 Jun 2026 · $3.6MAcquisition · 5 Jun 2026 · Not reportedAcquisition · 5 Jun 2026 · Not reportedAcquisition · 5 Jun 2026 · Not reportedAcquisition · 5 Jun 2026 · Not reportedAcquisition · 5 Jun 2026 · Not reportedAcquisition · 5 Jun 2026 · Not reportedAcquisition · 5 Jun 2026 · Not reportedAcquisition · 5 Jun 2026 · Not reportedAcquisition · 5 Jun 2026 · Not reportedAcquisition · 5 Jun 2026 · Not reportedDisposal · 5 Jun 2026 · $211.4KAcquisition · 3 Jun 2026 · Not reportedDisposal · 3 Jun 2026 · $532.3KAcquisition · 14 May 2026 · Not reportedAcquisition · 14 May 2026 · Not reportedDisposal · 14 May 2026 · $5.5MDisposal · 14 May 2026 · $1.3MDisposal · 14 May 2026 · $204.5KDisposal · 6 May 2026 · $384.4KDisposal · 5 May 2026 · $1.1MDisposal · 1 May 2026 · $5.0MDisposal · 30 Apr 2026 · $750.6KDisposal · 17 Mar 2026 · $1.9M
Feb 2025Aug 2026
Weekly closeCommon-share acquisitionCommon-share disposal

Market confirmation

Price and trend context

Latest close
35.36 USD
One-week move
+1.0%
Four-week move
+7.3%
Fair-value gap
+80.5%
Trend signal
Active
Relative strength
10.2

Directional balance

Controlled event mix

0.0%acquisition
Acquisition events
0
Disposal events
15
Net value
-$22.1M

Cadence

Twelve-week filing pressure

Volume shows attention. Controlled events determine direction.

925 May
2401 Jun
108 Jun
115 Jun
022 Jun
029 Jun
006 Jul
013 Jul
020 Jul
027 Jul
703 Aug
010 Aug

Named participants

Insider conviction by person

BARER, SOL JDirector500 events
CRANE, ROSEMARY ADirector500 events
ELSTEIN, AMIRDirector500 events
LICHTENSTEIN, CHENDirector500 events
LIEBERMAN, GERALD MDirector500 events
MIGNONE, ROBERTODirector500 events
NISEN, PERRYDirector500 events
SATCHI-FAINARO, RONITDirector500 events
ZAKS, TAL ZVIDirector281 events
HUGHES, ERIC ASee "Remarks"281 events
JOVER, PLACIDSee "Remarks"281 events
DANIELL, RICHARDEVP, Europe Commercial281 events

Evidence quality

Security and transaction context

Common equity30
Equity compensation24
Options and derivatives0
Other securities0

Role architecture

Who is participating

Director28
Other or unspecified20
CEO and chair3
Finance leadership2
Other executive1

Transaction evidence

Auditable TEVA filing ledger

Showing 1 to 30 of 54.

ZAKS, TAL ZVIDirector
DisposalCommon equity
17 sharesOrdinary Shares
$593Directional evidence
HUGHES, ERIC ASee "Remarks"
AcquisitionCommon equity
52744 sharesOrdinary Shares
Not reportedContext evidence
HUGHES, ERIC ASee "Remarks"
DisposalEquity compensation
52744 sharesRestricted Share Units
Not reportedContext evidence
JOVER, PLACIDSee "Remarks"
DisposalEquity compensation
12827 sharesRestricted Share Units
Not reportedContext evidence
JOVER, PLACIDSee "Remarks"
AcquisitionCommon equity
12827 sharesOrdinary Shares
Not reportedContext evidence
HUGHES, ERIC ASee "Remarks"
DisposalCommon equity
25578 sharesOrdinary Shares
$892.1KDirectional evidence
JOVER, PLACIDSee "Remarks"
DisposalCommon equity
12827 sharesOrdinary Shares
$447.4KDirectional evidence
SHIELDS, MATTHEWEVP, Global Operations
DisposalCommon equity
9989 sharesOrdinary Shares
$321.5KDirectional evidence
KALIF, ELIYAHU SHARONEVP, Chief Financial Officer
DisposalCommon equity
106563 sharesOrdinary Shares
$3.6MDirectional evidence
BARER, SOL JDirector
DisposalEquity compensation
21739 sharesRestricted Share Units
Not reportedContext evidence
BARER, SOL JDirector
AcquisitionCommon equity
21739 sharesOrdinary Shares
Not reportedContext evidence
CRANE, ROSEMARY ADirector
AcquisitionCommon equity
14492 sharesOrdinary Shares
Not reportedContext evidence
CRANE, ROSEMARY ADirector
DisposalEquity compensation
14492 sharesRestricted Share Units
Not reportedContext evidence
ELSTEIN, AMIRDirector
AcquisitionCommon equity
14492 sharesOrdinary Shares
Not reportedContext evidence
ELSTEIN, AMIRDirector
DisposalEquity compensation
14492 sharesRestricted Share Units
Not reportedContext evidence
FRANCIS, RICHARD DPresident and CEO
DisposalEquity compensation
13043 sharesRestricted Share Units
Not reportedContext evidence
FRANCIS, RICHARD DPresident and CEO
AcquisitionCommon equity
13043 sharesOrdinary Shares
Not reportedContext evidence
LICHTENSTEIN, CHENDirector
AcquisitionCommon equity
14492 sharesOrdinary Shares
Not reportedContext evidence
LICHTENSTEIN, CHENDirector
DisposalEquity compensation
14492 sharesRestricted Share Units
Not reportedContext evidence
LIEBERMAN, GERALD MDirector
AcquisitionCommon equity
14492 sharesOrdinary Shares
Not reportedContext evidence
LIEBERMAN, GERALD MDirector
DisposalEquity compensation
14492 sharesRestricted Share Units
Not reportedContext evidence
MIGNONE, ROBERTODirector
DisposalEquity compensation
14492 sharesRestricted Share Units
Not reportedContext evidence
MIGNONE, ROBERTODirector
AcquisitionCommon equity
14492 sharesOrdinary Shares
Not reportedContext evidence
NISEN, PERRYDirector
DisposalEquity compensation
14492 sharesRestricted Share Units
Not reportedContext evidence
NISEN, PERRYDirector
AcquisitionCommon equity
14492 sharesOrdinary Shares
Not reportedContext evidence
SATCHI-FAINARO, RONITDirector
AcquisitionCommon equity
14492 sharesOrdinary Shares
Not reportedContext evidence
SATCHI-FAINARO, RONITDirector
DisposalEquity compensation
14492 sharesRestricted Share Units
Not reportedContext evidence
ZAKS, TAL ZVIDirector
DisposalEquity compensation
14492 sharesRestricted Share Units
Not reportedContext evidence
ZAKS, TAL ZVIDirector
AcquisitionCommon equity
14492 sharesOrdinary Shares
Not reportedContext evidence
FRANCIS, RICHARD DPresident and CEO
DisposalCommon equity
6153 sharesOrdinary Shares
$211.4KDirectional evidence

Reading the dossier

Direction and confidence are separate

Conviction

The 0 to 100 score classifies deduplicated priced common-share evidence. Fifty is balanced or non-directional.

Confidence

Confidence rises with controlled event depth, named-insider breadth, fresh evidence, normalized values, and a longer observation span.

Disposals

Selling is not treated as the mirror image of buying. It carries less directional weight because taxes, diversification, compensation, and planned transactions can all create sales.

Price confirmation

The market chart tests whether the filing thesis is being confirmed or rejected by price, fair-value position, relative strength, and the current trend state.

Independent market research for education. This classification is not investment advice, a recommendation, a forecast, or an execution instruction.

Evidence context